About VALITOR, INC.
Valitor is a biotechnology company focused on developing next-generation ophthalmic medicines using multivalent biopolymer technology to improve patient outcomes in vision-threatening diseases. The company is advancing long-acting treatments for conditions like wet AMD.
Development of long-acting ophthalmic medicinesMultivalent biopolymer technology for extended therapeutic durabilityPipeline development using proven targets for ocular diseasesPreclinical and clinical development planning expertiseManufacturing and technical operations capabilities
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to VALITOR, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.